相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Elsa Sola et al.
JOURNAL OF HEPATOLOGY (2021)
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
Amaro Taylor-Weiner et al.
HEPATOLOGY (2021)
AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review
Puneeta Tandon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Javier Ampuero et al.
LIVER INTERNATIONAL (2021)
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy
Mattias Mandorfer et al.
HEPATOLOGY (2020)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum
Mazen Noureddin et al.
GASTROENTEROLOGY (2020)
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum
Oliver Glass et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
Sabela Lens et al.
JOURNAL OF HEPATOLOGY (2020)
Increasing burden of cirrhosis projected to 2040 in Canada: implications for prevention, screening, and management
Jennifer Flemming et al.
JOURNAL OF HEPATOLOGY (2020)
The progression of liver disease in 69,290 individuals in Wales from 1999–2019: tracking the evolution of liver disease
Tom Pembroke et al.
JOURNAL OF HEPATOLOGY (2020)
Nutrition in cirrhosis: Dos and Don'ts
Manuela Merli
JOURNAL OF HEPATOLOGY (2020)
Stratification of patients in NASH clinical trials: A pitfall for trial success
Javier Ampuero et al.
JHEP REPORTS (2020)
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
Ma Ai Thanda Han et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
A Comprehensive Review of Patient-reported Outcomes in Patients With Chronic Liver Diseases
Zobair M. Younossi et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
Candid Villanueva et al.
LANCET (2019)
NASH Is the Most Rapidly Growing Etiology for Acute-on-Chronic Liver Failure-Related Hospitalization and Disease Burden in the United States: A Population-Based Study
Page Axley et al.
LIVER TRANSPLANTATION (2019)
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal et al.
HEPATOLOGY (2019)
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee et al.
HEPATOLOGY (2019)
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis
Stephen A. Harrison et al.
GASTROENTEROLOGY (2018)
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2018)
Clinical states of cirrhosis and competing risks
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Is cryptogenic cirrhosis different from NASH cirrhosis?
Paul J. Thuluvath et al.
JOURNAL OF HEPATOLOGY (2018)
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options
Zobair Younossi et al.
JOURNAL OF HEPATOLOGY (2018)
Histological Severity and Clinical Outcomes of Nonalcoholic Fatty Liver Disease in Nonobese Patients
Jonathan Chung-Fai Leung et al.
HEPATOLOGY (2017)
Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?
Emanuela Orsi et al.
LIVER INTERNATIONAL (2017)
Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Parambir S. Dulai et al.
HEPATOLOGY (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
The Design of Clinical Trials in Portal Hypertension
Juan G. Abraldes et al.
SEMINARS IN LIVER DISEASE (2017)
13C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
Katarzyna Gorowska-Kowolik et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)
Development of hyperdynamic circulation and response to -blockers in compensated cirrhosis with portal hypertension
Candid Villanueva et al.
HEPATOLOGY (2016)
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults
Andrea Marengo et al.
CLINICS IN LIVER DISEASE (2016)
Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
Mattias Mandorfer et al.
JOURNAL OF HEPATOLOGY (2016)
Diabetes mellitus in patients with cirrhosis: clinical implications and management
Laure Elkrief et al.
LIVER INTERNATIONAL (2016)
Placebo effects in obesity research
Kevin R. Fontaine et al.
OBESITY (2016)
Association Between Severe Portal Hypertension and Risk of Liver Decompensation in Patients With Hepatitis C, Regardless of Response to Antiviral Therapy
Sabela Lens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Noninvasive assessment of liver function
Steve Helmke et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Serum Albumin Can Identify Patients With Compensated Cirrhosis With a Good Prognosis
Cristina Ripoll et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
Jaume Bosch et al.
JOURNAL OF HEPATOLOGY (2015)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis
Aldo J. Montano-Loza et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2015)
Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease
Yuya Seko et al.
HEPATOLOGY RESEARCH (2015)
Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis
Giada Sebastiani et al.
PLOS ONE (2015)
Health related quality of life in people with advanced chronic liver disease
James G. Orr et al.
JOURNAL OF HEPATOLOGY (2014)
The Natural History of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis or Cirrhosis: An International Collaborative Study
Neeraj Bhala et al.
HEPATOLOGY (2011)
Pathologic Criteria for Nonalcoholic Steatohepatitis: Interprotocol Agreement and Ability to Predict Liver-Related Mortality
Zobair M. Younossi et al.
HEPATOLOGY (2011)
Hypercoagulability in cirrhosis: causes and consequences
A. Tripodi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Diagnostic Value of the C-13 Methacetin Breath Test in Various Stages of Chronic Liver Disease
Hamizah Razlan et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2011)
Now There Are Many (Stages) Where Before There Was One: In Search of a Pathophysiological Classification of Cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2010)
Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Cecilia Soderberg et al.
HEPATOLOGY (2010)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
Vascular endothelial dysfunction in cirrhosis
Yasuko Iwakiri et al.
JOURNAL OF HEPATOLOGY (2007)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C
AJ Sanyal et al.
HEPATOLOGY (2006)
The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
Y Iwakiri et al.
HEPATOLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Long term prognosis of fatty liver: risk of chronic liver disease and death
S Dam-Larsen et al.
GUT (2004)
分享论文
